← Open Payments lookup

KATIE CUPP: Open Payments

NPI 1710343108 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,326 in 13 payments from 6 companies in 2025. Trend: 2023 $402 · 2024 $229 · 2025 $1,326

Consulting: $630Food & beverage: $604Education: $60Travel & lodging: $33
CompanyPaymentsAmount
GENZYME CORPORATION5$968
Boehringer Ingelheim Pharmaceuticals, Inc.3$149
AstraZeneca Pharmaceuticals LP2$110
SANOFI-AVENTIS U.S. LLC1$60
PFIZER INC.1$21
Novo Nordisk Inc1$18

Products named: DUPIXENT, OFEV, AIRSUPRA, JASCAYD, PREVNAR 20, Wegovy, TEZSPIRE.

Industry payments across NV — which companies pay providers there.